Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$628M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$608M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$518M |
| 4 |
Intel
INTC
|
+$172M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 2 |
Amazon
AMZN
|
+$437M |
| 3 |
Microsoft
MSFT
|
+$405M |
| 4 |
NVIDIA
NVDA
|
+$226M |
| 5 |
LyondellBasell Industries
LYB
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.07% |
| 2 | Financials | 5.69% |
| 3 | Healthcare | 5.49% |
| 4 | Consumer Discretionary | 4.41% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUAC
1651
DELISTED
ShoulderUp Technology Acquisition Corp.
SUAC
| $3.97M | ﹤0.01% |
400,001
| – | – |
|
|
CCXI
1652
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.95M | ﹤0.01% |
159,427
+117,029
| +276% | +$2.58M |
|
1653
Trex
TREX
$4.4B
| $3.95M | ﹤0.01% |
72,505
+3,031
| +4% | +$183K |
|
1654
PUT
Banco Bradesco
BBD
$37.5B
| $3.94M | ﹤0.01% |
1,210,000
| – | – |
|
1655
Charles River Laboratories
CRL
$11.3B
| $3.94M | ﹤0.01% |
18,422
-4,143
| -18% | -$1.01M |
|
1656
B&G Foods
BGS
$303M
| $3.93M | ﹤0.01% |
165,265
+103,664
| +168% | +$2.58M |
|
1657
Peloton Interactive
PTON
$2.85B
| $3.91M | ﹤0.01% |
425,886
-657,978
| -61% | -$10.6M |
|
1658
PUT
Norwegian Cruise Line
NCLH
$9.54B
| $3.89M | ﹤0.01% |
350,000
| – | – |
|
1659
iShares MSCI Indonesia ETF
EIDO
$464M
| $3.89M | ﹤0.01% |
173,911
+32,752
| +23% | +$789K |
|
1660
iShares Core MSCI EAFE ETF
IEFA
$186B
| $3.89M | ﹤0.01% |
66,067
-8,842
| -12% | -$567K |
|
1661
PVH
PVH
$4.07B
| $3.89M | ﹤0.01% |
68,339
+32,600
| +91% | +$2.25M |
|
|
CVET
1662
DELISTED
Covetrus, Inc. Common Stock
CVET
| $3.89M | ﹤0.01% |
187,291
+80,581
| +76% | +$1.43M |
|
1663
Crown Holdings
CCK
$13B
| $3.88M | ﹤0.01% |
42,146
-9,787
| -19% | -$1.05M |
|
1664
CareDx
CDNA
$1.83B
| $3.87M | ﹤0.01% |
180,114
+137,558
| +323% | +$3.81M |
|
1665
Insmed
INSM
$22.3B
| $3.86M | ﹤0.01% |
195,759
+148,323
| +313% | +$3.11M |
|
|
NTUS
1666
DELISTED
Natus Medical Inc
NTUS
| $3.85M | ﹤0.01% |
117,425
+84,628
| +258% | +$2.67M |
|
1667
STAG Industrial
STAG
$7.44B
| $3.85M | ﹤0.01% |
124,563
-54,557
| -30% | -$1.93M |
|
1668
Elbit Systems
ESLT
$36B
| $3.85M | ﹤0.01% |
16,892
+154
| +0.9% | +$32.2K |
|
1669
Moog Inc Class A
MOG.A
$12.3B
| $3.83M | ﹤0.01% |
48,310
-13,660
| -22% | -$1.11M |
|
1670
AAR Corp
AIR
$5.4B
| $3.83M | ﹤0.01% |
91,439
-19,645
| -18% | -$917K |
|
|
MGI
1671
DELISTED
MoneyGram International, Inc. New
MGI
| $3.82M | ﹤0.01% |
381,916
-194,539
| -34% | -$1.96M |
|
1672
PUT
NRG Energy
NRG
$26.2B
| $3.82M | ﹤0.01% |
100,000
| – | – |
|
1673
DraftKings
DKNG
$12.2B
| $3.81M | ﹤0.01% |
326,526
-340,140
| -51% | -$4.79M |
|
1674
Affirm
AFRM
$23.5B
| $3.79M | ﹤0.01% |
210,195
+25,186
| +14% | +$685K |
|
|
ICPT
1675
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.79M | ﹤0.01% |
274,504
+122,646
| +81% | +$1.96M |
|
Similar funds
Citigroup's Q2 2022 Portfolio in Review
As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
- Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
- Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
- Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
- Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
- Citigroup opened 507 new positions and closed 579 in Q2 2022.
- Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.